Published in Neurology on January 14, 2003
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 25.66
Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review. BMJ (2006) 2.95
MRI in multiple sclerosis: current status and future prospects. Lancet Neurol (2008) 2.08
Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry (2005) 1.59
Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol (2007) 1.51
Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations. J Neurol (2008) 1.46
The radiologically isolated syndrome: take action when the unexpected is uncovered? J Neurol (2010) 1.09
FLAIR imaging for multiple sclerosis: a comparative MR study at 1.5 and 3.0 Tesla. Eur Radiol (2005) 1.08
Mesenchymal stem cell transplantation in multiple sclerosis. J Neurol Sci (2013) 1.04
Hypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosis. BMC Neurol (2010) 0.95
Prevalence of celiac disease in multiple sclerosis. BMC Neurol (2011) 0.94
The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis? Eur Radiol (2013) 0.92
The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis. Immunotherapy (2012) 0.88
Escalating immunotherapy of multiple sclerosis--new aspects and practical application. J Neurol (2004) 0.88
Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology. J Neurol (2014) 0.84
The pros and cons of early treatment of relapsing forms of multiple sclerosis. J Neurol (2004) 0.83
Rationale for early intervention with immunomodulatory treatments. J Neurol (2008) 0.83
A prospective study of patients with brain MRI showing incidental t2 hyperintensities addressed as multiple sclerosis: a lot of work to do before treating. Neurol Ther (2014) 0.82
Acute transverse myelitis with normal brain MRI : long-term risk of MS. J Neurol (2007) 0.81
Interobserver agreement on the radiological criteria of the International Panel on the diagnosis of multiple sclerosis. Eur Radiol (2006) 0.80
MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof's criteria but different lesion patterns. J Neurol (2009) 0.79
Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis. Neurohospitalist (2013) 0.78
Economic evaluation of treating clinically isolated syndrome and subsequent multiple sclerosis with interferon beta-1b. Neurol Sci (2009) 0.78
Increased Female MS Incidence and Differences in Gender-Specific Risk in Medium- and High-Risk Regions in Finland from 1981-2010. Mult Scler Int (2013) 0.76
Patients with clinically isolated syndromes suggestive of MS: does MRI allow earlier diagnosis? Neurology (2003) 0.75
Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998-2007. BMC Neurol (2014) 0.75
Diagnostic algorithm for the differentiation of leukodystrophies in early MS. J Neurol (2008) 0.75
Optic neuritis as an early sign of multiple sclerosis. Eye Brain (2016) 0.75
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology (2006) 4.38
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology (2005) 3.45
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol (2008) 2.76
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology (2009) 2.58
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology (2007) 2.47
Prognostic significance of blood pressure variability after thrombolysis in acute stroke. Neurology (2008) 2.45
EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol (2010) 2.45
The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol (2001) 2.42
Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol (2000) 2.10
Scoring treatment response in patients with relapsing multiple sclerosis. Mult Scler (2012) 2.07
[Effectiveness of smoking cessation intervention in patients with cardiovascular disease]. Rev Esp Cardiol (2001) 1.93
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol (2011) 1.93
MRI criteria for MS in patients with clinically isolated syndromes. Neurology (2010) 1.90
Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study. Neurology (2009) 1.78
Cosmetic sequelae after conservative treatment for breast cancer: classification and results of surgical correction. Ann Plast Surg (1998) 1.72
Pituitary enlargement in patients with intracranial hypotension syndrome. Neurology (2000) 1.71
A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis. Brain (2009) 1.69
Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol (2000) 1.66
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results. Mult Scler (2009) 1.65
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63
Responsiveness and predictive value of EDSS and MSFC in primary progressive MS. Neurology (2008) 1.62
Lumbar extradural hemangiomas: report of three cases. AJNR Am J Neuroradiol (1999) 1.55
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology (2008) 1.53
[Neurologic manifestations of varicella herpes zoster infection]. Enferm Infecc Microbiol Clin (1995) 1.49
Measures in the first year of therapy predict the response to interferon beta in MS. Mult Scler (2009) 1.49
New anatomical classification of the axilla with implications for sentinel node biopsy. Br J Surg (2010) 1.46
Antiviral immune response in patients with multiple sclerosis and healthy siblings. Mult Scler (2010) 1.44
Plasma chitotriosidase activity in multiple sclerosis. Clin Immunol (2009) 1.44
STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann Rheum Dis (2008) 1.42
[Adnexal masses management: a prospective multicentric observational study]. Gynecol Obstet Fertil (2008) 1.42
Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology (2006) 1.42
Influence of different natural zeolite concentrations on the anaerobic digestion of piggery waste. Bioresour Technol (2001) 1.41
Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis. J Neuroimmunol (2010) 1.40
Towards a european network for multiple sclerosis trials (ENMST). Mult Scler (2003) 1.40
[Descriptive study of first visits in a multiple sclerosis specialised unit]. Neurologia (2002) 1.39
[Paroxysmal melanoptysis secondary to the cavitation of pulmonary pneumoconiosis conglomerate]. Arch Bronconeumol (1996) 1.39
[The role of zidovudine and cesarean section in the prevention of vertical transmission of HIV]. Med Clin (Barc) (1995) 1.38
[Body mass index influence in the insulin action mechanisms]. An Med Interna (1998) 1.38
[The development of multiple sclerosis following an isolated episode of optic neuritis. Magnetic resonance study]. Med Clin (Barc) (1997) 1.37
Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS? Mult Scler (2005) 1.36
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. Ann Oncol (2011) 1.33
Can the Expanded Disability Status Scale be assessed by telephone? Mult Scler (2003) 1.28
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology (2010) 1.27
Prospective evaluation of late cosmetic results following breast reconstruction: I. Implant reconstruction. Plast Reconstr Surg (2001) 1.27
Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer (2005) 1.26
Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann Neurol (2004) 1.25
Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology (2002) 1.25
Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction. Clin Cancer Res (2000) 1.24
The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun (2010) 1.22
Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.22
Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain (1999) 1.22
Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients. Mult Scler (2008) 1.21
Gray and white matter volume changes in early RRMS: a 2-year longitudinal study. Neurology (2005) 1.20
EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses. Eur J Neurol (2005) 1.20
A care bundle approach for prevention of ventilator-associated pneumonia. Clin Microbiol Infect (2012) 1.17
Resistance to cold and heat stress: accumulation of phenolic compounds in tomato and watermelon plants. Plant Sci (2001) 1.16
Complications of lymphadenectomy for gynecologic cancer. Eur J Surg Oncol (2012) 1.14
High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology (2004) 1.13
MRI findings in Möbius syndrome: correlation with clinical features. Neurology (2000) 1.13
Distribution territories and causative mechanisms of ischemic stroke. Eur Radiol (2005) 1.12
Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Endocr Relat Cancer (2006) 1.11
Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men. Ann Intern Med (2001) 1.11
Conservative treatment of breast cancers by mammaplasty and irradiation: a new approach to lower quadrant tumors. Plast Reconstr Surg (1995) 1.11
The stability of the Cdc6 protein is regulated by cyclin-dependent kinase/cyclin B complexes in Saccharomyces cerevisiae. J Biol Chem (2000) 1.10
mTOR signalling in human cancer. Clin Transl Oncol (2007) 1.09
Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis. Neurology (2006) 1.09